Published in Cancer on June 03, 2014
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. Gastroenterology (2015) 2.37
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer (2015) 1.25
Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol (2014) 0.99
Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health (2014) 0.99
Impact of provider-patient communication on cancer screening adherence: A systematic review. Prev Med (2016) 0.94
The impact of colorectal cancer screening on the US population: is it time to celebrate? Cancer (2014) 0.83
A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation. BMC Med Inform Decis Mak (2015) 0.75
Colon Capsule Endoscopy: Where Are We and Where Are We Going. Clin Endosc (2016) 0.75
Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial. Trials (2015) 0.75
Colonoscopy Screening among Native Hawaiians at Queen's Medical Center between August 2011 and January 2013. Hawaii J Med Public Health (2016) 0.75
The cost of cancer-related physician services to Medicare. Yale J Biol Med (2015) 0.75
The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study. BMC Med (2017) 0.75
Another brick in the large wall against colorectal cancer: a commentary on effectiveness of screening colonoscopy. Transl Gastroenterol Hepatol (2017) 0.75
Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88
Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity. J Clin Oncol (2014) 6.62
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol (2011) 4.07
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst (2012) 3.72
Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol (2012) 3.34
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J (2003) 3.11
Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol (2012) 3.07
Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. JAMA (2007) 3.03
Recruiting vulnerable populations into research: a systematic review of recruitment interventions. J Gen Intern Med (2007) 3.02
Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst (2006) 2.69
Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys (2010) 2.66
The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med (2012) 2.48
Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol (2007) 2.46
Effect of blinded peer review on abstract acceptance. JAMA (2006) 2.38
The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care (2011) 2.38
Sharing of clinical trial data among trialists: a cross sectional survey. BMJ (2012) 2.31
Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system. Oncology (Williston Park) (2012) 2.29
Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg (2012) 2.28
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol (2012) 2.18
The importance of clinical trial data sharing: toward more open science. Circ Cardiovasc Qual Outcomes (2012) 2.16
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology (2013) 2.16
Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care (2014) 2.14
NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01
Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park) (2010) 2.01
Anesthesiologist involvement in screening colonoscopy: temporal trends and cost implications in the medicare population. Clin Gastroenterol Hepatol (2011) 1.97
Use of hospital-based acute care among patients recently discharged from the hospital. JAMA (2013) 1.88
Physician violations of online professionalism and disciplinary actions: a national survey of state medical boards. JAMA (2012) 1.81
Assessing the impact of screening colonoscopy on mortality in the medicare population. J Gen Intern Med (2011) 1.73
Population based cancer registry analysis of primary tracheal carcinoma. Am J Clin Oncol (2011) 1.71
A retrospective review of 1349 cases of sebaceous carcinoma. Cancer (2009) 1.70
Validation of the partin nomogram for prostate cancer in a national sample. J Urol (2010) 1.64
Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database. J Urol (2010) 1.64
Laparoscopic colectomy for the treatment of cancer has been widely adopted in the United States. Dis Colon Rectum (2012) 1.62
Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population. Arch Dermatol (2012) 1.60
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.59
Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes. Leuk Res (2009) 1.57
Geographical information systems: applications and limitations in oncology research. Oncology (Williston Park) (2011) 1.52
Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients? Circulation (2003) 1.50
Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care. Med Care (2014) 1.50
A randomized outpatient trial of a decision-support information technology tool. Arch Intern Med (2005) 1.49
Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health (2011) 1.46
A historic moment for open science: the Yale University Open Data Access project and medtronic. Ann Intern Med (2013) 1.45
Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst (2006) 1.44
Hospital-level outcomes associated with laparoscopic colectomy for cancer in the minimally invasive era. J Gastrointest Surg (2012) 1.43
In regard to "Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series." (Int J Radiat Oncol Biol Phys 2012;83:624-629). Int J Radiat Oncol Biol Phys (2012) 1.37
Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood (2010) 1.34
Impact of comorbidity on mortality among older persons with advanced heart failure. J Gen Intern Med (2011) 1.31
The shortage of on-call surgical specialist coverage: a national survey of emergency department directors. Acad Emerg Med (2010) 1.27
Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys (2012) 1.25
Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation (2005) 1.24
Polypharmacy in older adults with cancer. Oncologist (2010) 1.23
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer (2011) 1.19
Online professionalism investigations by state medical boards: first, do no harm. Ann Intern Med (2013) 1.18
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol (2011) 1.16
The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population. J Urol (2011) 1.16
Contribution of individual diseases to death in older adults with multiple diseases. J Am Geriatr Soc (2012) 1.15
Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Heart Assoc (2014) 1.14
Multilevel interventions: study design and analysis issues. J Natl Cancer Inst Monogr (2012) 1.13
Integrating teaching skills and clinical content in a faculty development workshop. J Gen Intern Med (2003) 1.09
Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat. Health Aff (Millwood) (2012) 1.09
Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework. Arch Intern Med (2010) 1.08
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol (2009) 1.08
Risks and benefits associated with novel phase 1 oncology trial designs. Cancer (2007) 1.07
Sea change in open science and data sharing: leadership by industry. Circ Cardiovasc Qual Outcomes (2014) 1.05
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer (2012) 1.04
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys (2009) 1.03
Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008. Int J Radiat Oncol Biol Phys (2012) 1.02
Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol (2003) 1.01
Associations between mental health and surgical outcomes among women undergoing mastectomy for cancer. Breast J (2013) 1.00
The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications. Int J Radiat Oncol Biol Phys (2012) 1.00
Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Intern Med (2011) 1.00
A method for partitioning the attributable fraction of multiple time-dependent coexisting risk factors for an adverse health outcome. Am J Public Health (2012) 1.00
Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. Arch Intern Med (2012) 0.99
Use of postmastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys (2007) 0.98